PTIX
Protagenic Therapeutics, Inc.\new
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Net Income
$-5525344
↓ 10.5%
EPS (Diluted)
$-1.13
↑ 1.7%
Revenue
$0
NaN%
Total Assets
$2.0M
↓ 54.8%
Operating Income
$-5700950
↓ 25.9%
Total Liabilities
$942759.00
↑ 43.9%
Cash & Equivalents
$671091.00
↓ 16.0%
Shareholders' Equity
$1.0M
↓ 72.4%

Recent SEC Filings

Form Type Filed Date Link
NT 10-K 6/30/2026 View on SEC
8-K 4/7/2026 View on SEC
10-Q 3/9/2026 View on SEC
8-K 3/3/2026 View on SEC
8-K 2/24/2026 View on SEC
NT 10-Q 2/18/2026 View on SEC
25-NSE 1/23/2026 View on SEC
8-K 1/5/2026 View on SEC
DEF 14A 12/5/2025 View on SEC
10-Q 11/26/2025 View on SEC

Company Information

Field Value
Ticker PTIX
Company Name Protagenic Therapeutics, Inc.\new
CIK 1022899
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 0331
State of Incorporation DE
Phone (212) 994-8200